CURRENT ADVANCEMENTS AND COMPLICATIONS IN INTRATHECAL DRUG DELIVERY SYSTEM
DOI:
https://doi.org/10.22159/ijpps.2023v15i8.48573Keywords:
Intrathecal drug delivery systems, Complications, Considerations, Surgical complications, Medication-related side effects, Long-term useAbstract
Intrathecal drug delivery systems (IDDS) have emerged as a valuable treatment option for patients with chronic pain who have failed to achieve adequate relief with conventional therapies. These systems provide targeted delivery of medications directly to the cerebrospinal fluid, resulting in improved pain control and reduced systemic side effects. However, the use of IDDS is not without potential complications and considerations that must be addressed to ensure optimal patient outcomes. This comprehensive review examines the various complications associated with IDDS and the considerations that healthcare providers and patients need to be aware of. Surgical complications, such as infection, bleeding, spinal fluid leaks, and nerve damage, are discussed, along with strategies to minimize these risks. Device malfunctions, including pump failure, catheter issues, and electronic problems, are explored, highlighting the importance of regular monitoring and maintenance. Medication-related side effects, such as nausea, sedation, and respiratory depression, are addressed, emphasizing the need for close monitoring and appropriate dosage adjustments. Long-term considerations, including tolerance to medication, physical dependence, and withdrawal symptoms, are also examined, emphasizing the significance of gradual tapering and proper discontinuation protocols. The review underscores the importance of regular follow-up appointments to assess the system's functionality, medication dosages, and patient response to treatment. By proactively managing and addressing complications, healthcare providers can optimize pain relief and minimize adverse effects, ensuring the long-term effectiveness and safety of IDDS.
Downloads
References
Deer TR, Pope JE, Hayek SM, Lamer TJ, Veizi IE, Erdek M. The polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks. Neuromodulation. 2017;20(2):155-76. doi: 10.1111/ner.12579, PMID 28042914.
Kharkar S, Saffron BN, Krames E. Intrathecal therapy for cancer and nonmalignant pain. Neurotherapeutics. 2009;6(1):39-59.
Cohen SP, Hayek SM. Intrathecal drug delivery for pain. Curr Pain Headache Rep. 2016;20(6):34.
Brogan SE, Winter NB, Okifuji EA. Intrathecal drug delivery systems for refractory cancer pain. Curr Pain Headache Rep. 2014;18(1):390.
De Andres J, Grau J, Lopez Alarcon MD. Alpha-2 agonists for the treatment of chronic pain. J Pain Res. 2009;2:307-20.
Karoly P, Ruehlman LS. Psychosocial aspects of pain-related life task interference: an exploratory analysis in a general population sample. Pain Med. 2007;8(7):563-72. doi: 10.1111/j.1526-4637.2006.00230.x. PMID 17883741.
Davis RA, Emanski E, Racz GB. Technical factors that impact intrathecal drug delivery. Pain Phys. 2008;11(2):S89-S100.
Yang SY, Lee SM, Park KS. In vitro evaluation of antimicrobial efficacy of silver-coated polyurethane intrathecal catheters. Neurosurgery. 2017;81(2):326-32.
Lee B, Kim M, Yoon ES. A review of microinfusion pump technology for chronic pain management. Med Devices (Auckl). 2014;7:287-98.
Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology. 2005;216(2-3):106-21. doi: 10.1016/j.tox.2005.07.023, PMID 16140450.
Hamza M, Doleys D, Wells M, Weisbein J, Hoff J, Martin M. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012;13(10):1304-13. doi: 10.1111/j.1526-4637.2012.01451.x, PMID 22845187.
Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz Marx RL. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040-9. doi: 10.1200/JCO.2002.02.118, PMID 12351602.
Pope JE, Deer TR, Bruel BM, Falowski S. Clinical uses of intrathecal therapy and its placement in the pain care algorithm. Pain Pract. 2016;16(8):1092-106. doi: 10.1111/papr.12438.
Anderson VC, Burchiel KJ. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery. 1999;44(2):289-300. doi: 10.1097/00006123-199902000-00026, PMID 9932882.
Yaksh TL, Hassenbusch S, Burchiel K, Hildebrand KR, Page LM, Coffey RJ. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med. 2002;3(4):300-12. doi: 10.1046/j.1526-4637.2002.02048.x, PMID 15099235.
Smith TJ, Coyne PJ, Staats PS. An implantable drug delivery system (IDDS) for refractory cancer pain achieves substantial reductions in pain without limiting daily activities or quality of life. Pain Med. 2002;3(4):324-32.
Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM. Comprehensive consensus-based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Phys. 2011;14(3):E283-312. PMID 21587338.
Deer TR, Levy R, Prager J, Buchser E, Burton A, Caraway D. Polyanalgesic consensus conference–2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation Polyanalgesic Consensus Conference. 2012;15(5):467-82. doi: 10.1111/j.1525-1403.2012.00486.x, PMID 22849581.
Raffaeli W, Bernardini B, Reale C. Intrathecal drug delivery systems for the management of chronic non-cancer pain: safety and effectiveness results from a 300 patient Italian cohort. Minerva Anestesiol. 2015;81(4):422-30.
Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 mo: a randomized comparative trial. Pain. 2017;158(4):669-81. doi: 10.1097/j.pain.0000000000000814, PMID 28030470.
Brogan SE. Intrathecal drug delivery systems for cancer pain: an update. Cancer Control. 2017;24(1):1073274817729242.
Harrison C, Epton S, Bojanic S, Green AL, FitzGerald JJ. The efficacy and safety of dorsal root ganglion stimulation as a treatment for neuropathic pain: a literature review. Neuromodulation. 2018;21(3):225-33. doi: 10.1111/ner.12685. PMID 28960653.
Deer TR, Pope JE, Hayek SM, Lamer TJ, Veizi IE, Erdek M. The polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks. Neuromodulation. 2017;20(2):155-76. doi: 10.1111/ner.12579, PMID 28042914.
Cusson E, Shenouda PE, Bradley WT. Accuracy of radio-frequency identification technology for detection of intrathecal drug delivery system catheter position. Reg Anesth Pain Med. 2017;42(5):578-82.
Prager J, Deer T, Levy R, Bruel B, Buchser E, Caraway D. Best practices for intrathecal drug delivery for pain. Neuromodulation. 2014;17(4):354-72. doi: 10.1111/ner.12146, PMID 24446870.
Rigoard P, Desai MJ, North R. Intrathecal drug delivery systems for the management of noncancer pain: recommendations from the international neuromodulation society polyanalgesic consensus conference. Neuromodulation. 2016;19(4):436-64.
Hassenbusch SJ, Portenoy RK, Cousins M. Polyanalgesic consensus conference 2003: an update on the management of pain by intraspinal drug delivery– report of an expert panel. J Pain Symptom Manage Polyanalgesic Consensus Conference. 2004;27(6):540-63. doi: 10.1016/j.jpainsymman.2004.03.001, PMID 15165652.
Burton AW, Rajagopal A, Shah HN. Long-term outcomes of patients receiving combined intrathecal ziconotide and morphine: a case series. Pain Med. 2008;9(7):841-7.
Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg. 1990;72(2):200-9. doi: 10.3171/jns.1990.72.2.0200, PMID 1688618.
Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non-cancer pain. Pain Phys. 2011;14(3):219-48. PMID 21587327.
Deer TR, Pope JE, Hayek SM, Lamer TJ, Veizi IE, Erdek M.. The polyanalgesic consensus conference (PACC): recommendations for intrathecal drug delivery: guidance for improving safety and mitigating risks. Neuromodulation. 2017;20(2):155-76. doi: 10.1111/ner.12579. PMID 28042914.
Chang MC, Kim TU. Commentary on the article “A randomized comparative trial of targeted steroid injection via epidural catheter vs standard transforaminal epidural injection for the treatment of unilateral cervical radicular pain: six-month results” by McCormick. Pain Med. 2021;22(6):1461-2. doi: 10.1093/pm/pnaa479. PMID 33619559.
Coffey RJ, Edgar TS, Francisco GE, Graziano FM, Meyerson BA, Traynelis VC. Abracadabra: guidelines for the use of intrathecal infusion in the management of chronic noncancer pain. Neuromodulation Technol Neural Interface. 2021;24(3):393-412. doi: 10.1111/ner.13387.
Hubbard JE, Hodge SD. The litigation complexity of posttraumatic headaches. Curr Pain Headache Rep. 2021;25(6):39. doi: 10.1007/s11916-021-00954-3. PMID 33821382.
Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S. The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96-132. doi: 10.1111/ner.12538. PMID 28042904.
Munoz L, Bree D, Rizk E, Saiz Sapena N, Bara J, Abejon D. Update on intrathecal drug delivery for chronic pain and spasticity: a narrative review. Pain Ther. 2021;10(1):213-26. doi: 10.1007/s40122-020-00227-2.
Kumar K, Hunter G, Demeria D. Spinal cord stimulation in treatment of chronic benign pain: challenges in treatment planning and present status, a 22 y experience. Neurosurgery. 2006;58(3):481-96. doi: 10.1227/01.NEU.0000192162.99567.96. PMID 16528188.
Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes’ B2 or C colon cancer: a North Central Cancer Treatment Group Study. J Clin Oncol. 2004;22(9):1572-82. doi: 10.1200/JCO.2004.10.042. PMID 15117979.
Falowski SM, Sharan AD, McLaughlin N. Chronic intrathecal drug infusion: evolving challenges and potential solutions. J Neurosurg Spine. 2020;33(1):1-9. doi: 10.3171/2020.1.
Hamza M, Doleys D, Wells M, Weisbein J, Hoff J, Martin M. Prospective study of 3 y follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012;13(10):1304-13. doi: 10.1111/j.1526-4637.2012.01451.x. PMID 22845187.
Atli A, Theodore BR, Turk DC, Loeser JD, Ruiz Lopez R. Critical issues in intrathecal therapy. Pain Med. 2004;5(3):303-15. doi: 10.1111/j.1526-4637.2004.
Vik A, Zwart JA, Nygaard, Hulleberg G. Eight year outcome after surgery for lumbar disc herniation: a comparison of reoperated and not reoperated patients. Acta Neurochir. 2001;143(6):607-11. doi: 10.1007/s007010170066.
Brogan SE, Winter NB, Abelson HT, Madsen RW. Long-term intrathecal opioids and bupivacaine in the management of pain caused by failed back surgery syndrome. Pain Phys. 2006;9(1):71-6.
Smith HS, Deer TR, Staats PS, Singh V, Sehgal N. Emerging technologies in intrathecal therapy. Pain Phys. 2006;9(2):195-202.
Corrigendum. Pain Med. 2019;20(11):2333. doi: 10.1093/pm/pny268. PMID 30481365.
Elahi F, Reddy C, Bellinger A, Manolitsis N. Neuromodulation of the great auricular nerve: a case report. Neuromodulation. 2014;17(8):784-7. doi: 10.1111/ner.12114. PMID 25521167.
Chandy L, Durga P, Rashid M, Bansal P. Efficacy of intrathecal drug delivery system in chronic noncancer pain: a systematic review and meta-analysis. Pain Res Manag. 2020. doi: 10.1155/2020/2947083.
Duarte RV, Rafael A, Raphael JH. Systematic review and meta-analysis of intrathecal ziconotide for chronic pain. Pain Phys. 2018;21(6):589-603.
Raffaeli W, Sarti D, Demartini L, Mariani L, De Gaudio AR, Fanelli G. Comparison between intrathecal morphine and ziconotide for chronic pain: a literature review. Minerva Anestesiol. 2018;84(7):863-70. doi: 10.23736/S0375-9393.18.12216-2.
Ball RD. The science of conventional and water-cooled monopolar lumbar radiofrequency rhizotomy: an electrical engineering point of view. Pain Phys. 2014;17(2):E175-211. PMID 24658487.
Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S. The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96-132. doi: 10.1111/ner.12538. PMID 28042904.
Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A. Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation Technol Neural Interface. 2017;15(5):436-64. doi: 10.1111/j.1525-1403.2012.
Liao CD, Rau CL, Liou TH, Tsauo JY, Lin LF. Effects of linearly polarized near-infrared irradiation near the stellate ganglion region on pain and heart rate variability in patients with neuropathic pain. Pain Med. 2017;18(3):488-503. doi: 10.1093/pm/pnw145. PMID 27452896.
Hochberg U, Ojeda A, Brill S, Perez J. An internet-based survey to assess clinicians’ knowledge and attitudes towards opioid-induced hypogonadism. Pain Pract. 2019;19(2):176-82. doi: 10.1111/papr.12731. PMID 30269435.
Akdeniz E, Bolat MS, Akdeniz S. A comparison of prilocaine vs prilocaine+bupivacaine in periprostatic block in ambulatory prostate biopsies: a single-blind randomized controlled study. Pain Med. 2018;19(10):2069-76. doi: 10.1093/pm/pnx249. PMID 29177501.
Winkelmüller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg. 1996;85(3):458-67. doi: 10.3171/jns.1996.85.3.0458. PMID 8751633.
El-Yahchouchi CA, Willard FH, Kaufmann TJ, Wald JT, Diehn FE, Geske JR. Synovial cysts confounding access to the dorsal S1 neural foramen in transforaminal epidural steroid injections. Pain Med. 2020;21(3):570-5. doi: 10.1093/pm/pnz298. PMID 32142149.
Rojas AC, Alves JG, Moreira E Lima R, Esther Alencar Marques M, Moreira de Barros GA, Fukushima FB. The effects of subarachnoid administration of preservative-free S(+)-ketamine on spinal cord and meninges in dogs. Anesth Analg. 2012;114(2):450-5. doi: 10.1213/ANE.0b013e31823a5d1b. PMID 22167772.
Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science. 1976;192(4246):1357-8. doi: 10.1126/science.1273597. PMID 1273597.
Hama A, Sagen J. Spinal antinociceptive effects of hydromorphone and morphine in a rat model of cancer pain. Anesth Anal. 2014;118(1):216-23. doi: 10.1213/ANE.0b013e3182a518c4.
Sagen J, Proudfit HK, Johnson RD. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurochem. 1990;55(2):614-21. doi: 10.1111/j.1471-4159.
Guo TZ, Huang LY. Presynaptic modulation of excitatory synaptic transmission by κ-opioid receptors in the rat spinal cord. Br J Pharmacol. 1991;102(2):397-400. doi: 10.1111/j.1476-5381.
Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986;64(6):790-4. doi: 10.1097/00000542-198606000-00019. PMID 3717642.
Menetrey D, Basbaum AI. Spinal and trigeminal lamina I input to the locus coeruleus antinociceptive system. Neuroscience. 1987;23(1):183-93. doi: 10.1016/0306-4522(87)90251-3.
Liu NJ, Gintzler AR. Spinal endomorphin-2 antinociception requires endogenous enkephalins acting on δ and μ opioid receptors in the rat. J Pharmacol Exp Ther. 1999;290(2):840-6.
Vanderah TW, Largent Milnes TM, Lai J. Novel, long-acting delta opioid receptor agonists for pain treatment. J Pharmacol Exp Ther. 2016;358(1):9-15. doi: 10.1124/jpet.116.232413.
Salengros JC, Velghe Lenelle CE, Bollens R, Engelman E, Barvais L. Lactic acidosis during propofol-remifentanil anesthesia in an adult. Anesthesiology. 2004;101(1):241-3. doi: 10.1097/00000542-200407000-00036. PMID 15220797.
Smith HS, Deer TR. Safety and efficacy of intrathecal methadone in patients with chronic pain: a retrospective analysis. J Pain Symptom Manag. 2009;37(5):747-52. doi: 10.1016/j.jpainsymman.2008.04.013.
Coluzzi F, Valensise H, Sacco M, Allegri M, Bachiocco V. Methadone in cancer pain management: a practical guide. Support Care Cancer. 2010;18(5):621-9. doi: 10.1007/s00520-010-0880-1.
Elkassabany NM, Nelson C. Intrathecal methadone in the management of chronic nonmalignant pain: a case report. Pain Pract. 2011;11(3):289-92. doi: 10.1111/j.1533-2500.2010.
Smith HS, Moulin DE. Improving opioid safety and efficacy. Pain Res Treat. 2012. doi: 10.1155/2012/914902.
Johnson PN, Varma MG, Cardinal LO. Intrathecal methadone for cancer pain management: a case series. J Pain Palliat Care Pharmacother. 2015;29(3):257-64. doi: 10.3109/15360288.2015.1042645.
Kim MS, Cheong YK, Choi JH, Kim K. Intrathecal methadone for refractory cancer pain: a report of four cases. Korean Journal of Pain. 2016;29(3):199-203. doi: 10.3344/kjp.2016.29.3.199.
Gupta B, Garg N, Ramachandran R. Vasopressors: do they have any role in hemorrhagic shock? J Anaesthesiol Clin Pharmacol. 2017;33(1):3-8. doi: 10.4103/0970-9185.202185. PMID 28413267.
Shen J, Xu S, Xu S, Ye S, Hao J. Fusion or not for degenerative lumbar spinal stenosis: a meta-analysis and systematic review. Pain Phys. 2018;21(1):1-8. PMID 29357326.
Wankhede V, Buchser E. A case of pocket fill causing baclofen withdrawal. Neuromodulation. 2019;22(7):843-4. doi: 10.1111/ner.12887. PMID 30506761.
You DS, Hah JM, Collins S, Ziadni MS, Domingue BW, Cook KF. Evaluation of the preliminary validity of misuse of prescription pain medication items from the patient-reported outcomes measurement information system (PROMIS)®. Pain Med. 2019;20(10):1925-33. doi: 10.1093/pm/pnz001. PMID 30856659.
Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S. The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96-132. doi: 10.1111/ner.12538. PMID 28042904.
Mehta Y, Arora D, Sharma KK. Intrathecal opioid use in the management of chronic noncancer pain. J Anaesthesiol Clin Pharmacol. 2020;36 Suppl 1:S17-23. doi: 10.4103/joacp. JOACP_189_19.
Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S. The polyanalgesic consensus conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines. Neuromodulation. 2017;20(2):96-132. doi: 10.1111/ner.12538. PMID 28042904.
UK: physician’s Press. Medtronic.com. Available from: http://wwwp/pain/idd_equipment.html. [Last accessed on 01 Jun 2023]
Tekade RK. Chapter 6. Approaches to the development of implantable therapeutic systems. In: Biomaterials and bionanotechnology. London: Elsevier/Academic Press; 2019.
Published
How to Cite
Issue
Section
Copyright (c) 2023 ABDUL MANNAN, MOHAMMED FAHAD, FAIZAH AYESHA AMJAD, JUVERIA FATIMA
This work is licensed under a Creative Commons Attribution 4.0 International License.
